CANECT-HD
Live / Applied — Second extension granted (statement of use) (as of 17 Nov 2025)
What this means for you
Not registered yet, but its 19 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98365357
- Mark type
- Stylized text
- Filed
- 19 Jan 2024
- Published for opposition
- 01 Oct 2024
- Attorney of record
- Allison Strickland Ricketts
Goods and services
- Class 042 — Scientific and technological services: Providing medical research information in the field of pharmaceuticals and clinical trials focusing on Huntington's disease, chorea associated with Huntington's disease, chorea, and neurodegenerative and movement disorders; Scientific research in the nature of conducting clinical trials for pharmaceutical preparations for the treatment of Huntington's disease, chorea associated with Huntington's disease, chorea, and neurodegenerative and movement disorders, for others; Conducting research in the field of pharmaceuticals for evaluating epidemiological results; Conducting research in the field of pharmaceuticals for evaluating patients in the field of Huntington's disease, chorea associated with Huntington's disease, chorea, and neurodegenerative and movement disorders
- Class 044 — Medical, beauty and agricultural services: Providing medical information to patients, medical professionals, and insurance companies in the field of Huntington's disease, chorea associated with Huntington's disease, chorea, and neurodegenerative and movement disorders; Online information services, namely, providing medical information to patients, medical professionals, and insurance companies in the field of Huntington's disease, chorea associated with Huntington's disease, chorea, and neurodegenerative and movement disorders; Providing pharmaceutical consultancy services
Owner
- Neurocrine Biosciences, Inc., San Diego, CA, US
- Neurocrine Biosciences, Inc., San Diego, CA, US
Prosecution history
- 17 Nov 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Nov 2025 — SOU EXTENSION 2 GRANTED
- 17 Nov 2025 — SOU EXTENSION 2 FILED
- 17 Nov 2025 — SOU TEAS EXTENSION RECEIVED
- 22 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 May 2025 — SOU EXTENSION 1 GRANTED
- 21 May 2025 — SOU EXTENSION 1 FILED
- 21 May 2025 — SOU TEAS EXTENSION RECEIVED
- 20 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 20 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 20 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 26 Nov 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Oct 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 01 Oct 2024 — PUBLISHED FOR OPPOSITION
- 11 Sept 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED